Here at Qmetis, we believe in the science of evidence-based medicine. We built our company around it. But more than anything else, Qmetis is an education company, a healthcare technology firm building quality assessment and quality assurance decision-support tools for caregivers that deliver evidence-based medicine treatment guidelines in real-time, at the bedside.
Our fast, easy, and interactive decision-support tools are designed to inform staff instantly of the latest research and recommendations, allowing them to consider all options for their patient’s care. Our tools make measurable marks on performance improvement, quality assessment, and variance in care, wherever they go.
Our first products are for adult, and pediatric traumatic brain injury soon joined by our decision-support tools for stroke, hospital-acquired infections, and concussion. Welcome to Qmetis.
Jack Fitzgibbons (President and COO) is a founder of EBM Care. Prior to founding EBM Care/Qmetis in 2012, Mr. Fitzgibbons was the managing director of CarePath, Inc, a medical informatics company grounded in the science of evidence-based medicine. Fitzgibbons served as the managing director and chief business officer of CarePath from 2008 through 2012 and led it from the concept stage to its first revenue and profitability. Prior to CarePath, he founded a marketing agency, Red Bridge Road, with a focus on non-profit development and healthcare. Jack’s earlier career was also in marketing serving as a senior marketing executive with the National Football League and the United States Tennis Association. And Jack is also the acting director of the Qmetis and EBM Care Foundations.
Emily Graham (Director of Operations) was educated at California State University, Fullerton (BA) and New York University (MPH) and brings over five years of experience in program implementation, hospital administration, and public health management to Qmetis. Emily is responsible for overseeing all day to day operations in Qmetis’s New York office, as well as managing relationships with hospital stakeholders and facilitating hospital feedback. In addition, Emily plays an integral part in product development with Qmetis’s clinical partners and will have a leading role in the development of Qmetis’s new business unit, QFutures. Emily previously worked at UCLA Health in the Office of the Patient Experience on numerous quality improvement initiatives and brings a public health perspective to Qmetis’s work with her Master’s in Public Health.
Ken Brijlall (Director of Technology and Innovation) was educated at Cooper Union (BSE) and New York University (MBA), Ken has over a decade of experience in software and delivery management. His expertise within software development spans the entire life cycle which includes project initiation, planning, execution, monitoring, controlling, testing, and release. He has developed small to enterprise-scale technology solutions with knowledge and experience in a variety of industries, including financial services and healthcare, making him a welcome addition to the Qmetis team. Ken’s role involves leading the hospital integration programs, directing the core software product(s) development, and conducting training and hospital outreach efforts.
John Bazin (Chief, External and Corporate Affairs) has more than 25 years of leadership experience with Fortune 200 companies such as Anheuser-Busch, Bristol-Myers Squibb, Waste Management, and Cendant Corp., where he spent six years building a government affairs program from the ground up. Bazin’s diverse experience spans consumer products, information technology, health care, pharmaceutical, environmental, energy, travel and tourism, hospitality, aviation, real estate, and financial services. His expertise covers all aspects of a modern, sophisticated government relations function, including procurement, issue management, policy and research, opinion research, lobbying, grassroots, political giving strategies, and trade association management and coalition building.
Harrison G. Frank, MD (Chief Medical Advisor) is a former neurosurgeon who began his career at Wake Forest Baptist Health in Winston Salem, NC. He received his undergraduate degree from the University of Wisconsin-Stevens Point and attended medical school at Jefferson Medical College.
Dr. Frank is currently a rehabilitation physician with specializations in rehabilitation and regenerative medicine. He is the Founder and Medical Director for Frank Institute for Health and Wellness and Co-Founder and CEO of Deacon Technologies, LLC, with interests in and a focus on the development of real-time integrative software for brain and spinal cord management, as well as sideline management for the prevention of serious medical conditions.
Dr. Frank’s research and publications include “Fixation of Tibial Spine Eminence Fractures Using Sutures,” “Arthroscopic Fixation of Tibial Eminence Fractures,” and “Simultaneous Primary Total Hip Arthoplasty and Contra Lateral Revision Hip Arthroplasty: Role for Use of Femoral Head Autograft.”
Dr Frank also has a significant athletic background, having spent time as a professional basketball player in the Israeli Professional League, the USBL and CBA here in the states, and time in the NBA.
Board of Advisors
Timothy C. Ryken, MD
Dr. Ryken is a neurosurgeon at the University of Kansas Medical Center in Kansas City. He attended Iowa State University, majoring in biochemistry, where he was elected to Phi Beta Kappa. He completed medical school at the University of Iowa in 1984. Dr. Ryken received one of the highest honors available to neurosurgical residents, being named the American Association of Neurological Surgeon VanWagenen Fellow for 1995, and was awarded a year of study at the University of Cambridge, where he developed techniques for genetic modification of central nervous system cells.
Dr. Ryken joined the faculty at the State University of New York, Department of Neurosurgery, in Syracuse in 1996. He was the first recipient of the Robert and Molly King Endowed Chair in Neuroscience for research in brain tumor treatments. He subsequently returned to the University of Iowa, Division of Neurosurgery, as assistant professor in 1998 to further develop therapies for central nervous system neoplasia.
In addition to his interest in central nervous system tumors, he has been extensively involved in spinal surgery. He received the Mayfield Award of the Joint Section on Spine and Disorder of the Peripheral Nerves in 1994 and has numerous publications in spinal biomechanical studies. He co-authored the widely quoted AANS/CNS sponsored publication on Guideline for the Management of Acute Spine and Spinal Cord Injuries. He is also involved nationally with the AANS/CNS Joint Section on Tumors, the Society for Neuro-oncology, the Society for Neuroscience, and the American Association of Cancer Research. He is currently a member of the AANS/CNS Joint Section on Tumors task force on development for Guideline in the Initial Management of Malignant Glioma.
Mr. VictorF. Ganzi currently serves as Chairman of PGA TOUR Inc. Ganzi served as theChief Executive Officerof Hearst Corp. from 2002 to 2008.Prior to that, he was COO from 1998 to 2002, and executive vice president from 1997 to 2002.
From 1992 to 1997, Ganzi served in various positions including senior vice president, CFO and chief legal officer. He also served as a COO at Hearst Interactive Media. Ganzi also served as Group Head of Books, Business Publishing Group of Hearst from March 1995 to October 1999. He began his career at Hearst in 1990 as General Counsel and Vice President. Prior to joining Hearst, Ganzi served as the Managing Partner at Rogers & Wells (now Clifford Chance).
He serves as Co-‐Chairman of Partnership for New York.He serves as Vice Chairman of New York City Economic Development Corp. He serves as a testamentary Trustee of the trust established under the will of William Randolph Hearst.
He has been a Director of Wyeth, LLC since 2005 and Gentiva Health Services, Inc. since 1999. He has been Lead Director of Gentiva Health Services, Inc. since May 2009. He serves as a Corporate Director at Towers Watson & Co and served as its Consultant. He serves as a Director of The National Magazine Company Ltd., ADO Staffing, Inc., ESPN, Palm Management Corporation, William Randolph Hearst Foundation andThe Hearst Foundation Inc.
He practiced as a Certified Public Accountant in Taxation at a Big Four accounting firm in Denver. He graduated summa cum laude from Fordham University in 1968. Mr. Ganzireceived a J.D. degree from Harvard Law School in 1971, a BS in accounting from Fordham University, and an L.L.M. in Taxation from New York University in 1981.
Jeanine “Nini” Martin
Ms. Martin is currently the Global Chief Growth Officer at C3 Global Biosciences (leaders in CBD R&D, innovation and education). She is a Nurse Advocate, Clinical Informatician (Johns Hopkins University School of Medicine) and a Healthcare IT Executive for the past 25+ years.
Nini is a (Bill) Gates Fellow and former Member of Microsoft’s Global Health Strategy Committee that helped to build the 1st US Health & Life Sciences LOB from its inception to a $2.5B vertical industry business unit. She is a Founding Officer of the Tennessee HIMSS Chapter. She is the Founding President of Women in Technology of Tennessee and the past President of Women in Technology International (WITI). She is the past President of the International Association of IT Professionals (Tennessee Chapter), the former President-elect of the Nashville PMI Chapter and an Advisory Board Member of ASCO (American Society of Clinical Oncology). Nini is a former Olympic-level athlete, former Marketing Advisor for the 1st Women’s NFL and Council Member of Athletes for Care to advocate solutions for Health, Wellness & Fitness.
Marty B. Scott, MD, MBA
Dr. Scott is senior vice president and chief quality officer for Meridian Health. He completed his undergraduate work at David Lipscomb College in Nashville and earned his medical degree at the University of Louisville. Dr. Scott served as a pediatric resident at the University of Louisville Affiliated Hospitals and Kosair Children’s Hospital. He was selected for fellowship training in pediatric critical care at the University of Miami Jackson Memorial Hospital. He was a clinical assistant professor of pediatrics at Mercer University School of Medicine.
Dr. Scott served as vice president for patient safety and quality initiatives at Memorial University Medical Center (MUMC) in Savannah, Georgia, and held clinical responsibilities in the pediatric intensive care unit there. While at MUMC, he was director of patient safety and quality for the George and Marie Backus Children’s Hospital and the Women’s Health Institute. Dr. Scott joined Wake Forest Baptist Health as vice president of Brenner Children’s Hospital in October 2010, and as a leader in children’s health care and administration, Scott served as Brenner’s senior administrative executive.
With a career-long focus on quality in health care, Dr. Scott has led initiatives that reduced medication errors and events of patient harm. He is a certified patient safety officer and holds Six Sigma Black Belt certification for quality control expertise.
Board of Directors
Jack Fitzgibbons (See Leadership)
Michael Garcia is the owner and president of Garcia Lindsey Group, an executive recruiting firm based in Savannah, GA. Garcia Lindsey Group specializes in recruiting for organizations that need to evolve and manage change.
Prior to starting the Garcia Lindsey Group, he was a managing director at two retained search firms in the New York City area. Michael worked in the travel industry prior to becoming a recruiter, serving as president of Auto Europe, a travel-related company in Portland, ME, and in a series of domestic and international marketing and sales positions for the Hertz Corporation, a worldwide car rental company.
He began his career in the advertising agency business, eventually serving as the president and CEO of Campbell Mithun’s offices in Chicago, IL, and Toronto, Canada, before moving to Hertz.
John Bazin (See Leadership)
Harrison G. Frank, MD (See Leadership)
Want to see how Qmetis can help you reduce costs and improve outcomes?